Jifang Sheng

18.1k total citations · 3 hit papers
161 papers, 7.1k citations indexed

About

Jifang Sheng is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Jifang Sheng has authored 161 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Epidemiology, 58 papers in Infectious Diseases and 51 papers in Hepatology. Recurrent topics in Jifang Sheng's work include Liver Disease Diagnosis and Treatment (40 papers), COVID-19 Clinical Research Studies (32 papers) and Liver Disease and Transplantation (27 papers). Jifang Sheng is often cited by papers focused on Liver Disease Diagnosis and Treatment (40 papers), COVID-19 Clinical Research Studies (32 papers) and Liver Disease and Transplantation (27 papers). Jifang Sheng collaborates with scholars based in China, United States and Switzerland. Jifang Sheng's co-authors include Lanjuan Li, Anwen Shao, Sheng Tu, Kaijin Xu, Hong Fang, Hongliu Cai, Yunqing Qiu, Hainv Gao, Xiaowei Xu and Xiaoxin Wu and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Jifang Sheng

153 papers receiving 7.0k citations

Hit Papers

Clinical findings in a gr... 2019 2026 2021 2023 2020 2019 2024 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
    2020 1.5k citations Xiaoxin Wu, Kaijin Xu et al. profile →
  2. Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment
    2019 701 citations Hong Fang, Sheng Tu et al. Journal of Cellular and Molecular Medicine profile →
  3. ATP‐Responsive Manganese‐Based Bacterial Materials Synergistically Activate the cGAS‐STING Pathway for Tumor Immunotherapy
    2024 63 citations Jifang Sheng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jifang Sheng China 39 2.6k 1.8k 1.2k 1.1k 1.0k 161 7.1k
Giovanni Guaraldi Italy 46 4.0k 1.5× 3.1k 1.7× 354 0.3× 598 0.5× 812 0.8× 407 9.4k
Gabriel Chodick Israel 44 1.5k 0.6× 1.2k 0.7× 386 0.3× 751 0.7× 167 0.2× 378 8.2k
Claudio Maria Mastroianni Italy 41 2.8k 1.1× 1.7k 0.9× 867 0.7× 919 0.8× 426 0.4× 354 6.7k
Gianvincenzo Zuccotti Italy 51 2.2k 0.8× 2.5k 1.4× 283 0.2× 1.6k 1.5× 212 0.2× 700 11.8k
André Scherag Germany 39 802 0.3× 4.6k 2.6× 373 0.3× 1.8k 1.6× 411 0.4× 177 10.8k
Melchor Álvarez‐Mon Spain 44 807 0.3× 2.3k 1.3× 195 0.2× 1.7k 1.5× 1.7k 1.6× 347 8.9k
Fang Liu China 30 2.8k 1.1× 1.2k 0.6× 1.6k 1.3× 594 0.5× 207 0.2× 156 5.4k
Ammarin Thakkinstian Thailand 51 506 0.2× 1.4k 0.8× 224 0.2× 1.1k 1.0× 387 0.4× 351 10.0k
Long H. Nguyen United States 38 800 0.3× 1.2k 0.6× 293 0.2× 2.3k 2.1× 514 0.5× 140 7.1k
Karla Soares‐Weiser United Kingdom 41 878 0.3× 953 0.5× 396 0.3× 194 0.2× 775 0.8× 97 5.2k

Countries citing papers authored by Jifang Sheng

Since Specialization
Citations

This map shows the geographic impact of Jifang Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jifang Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jifang Sheng more than expected).

Fields of papers citing papers by Jifang Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jifang Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jifang Sheng. The network helps show where Jifang Sheng may publish in the future.

Co-authorship network of co-authors of Jifang Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jifang Sheng. A scholar is included among the top collaborators of Jifang Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jifang Sheng. Jifang Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xianghua, Na Wu, Qirui Hu, et al.. (2025). Research on the anti-aging activity of different mulberry leaf Products: Based on mulberry leaf powder and mulberry leaf extract. Food Bioscience. 69. 106785–106785. 1 indexed citations
2.
3.
4.
5.
Yan, Lan, et al.. (2024). Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis. BMC Gastroenterology. 24(1). 408–408. 1 indexed citations
6.
Gao, Shiqi, et al.. (2021). Pathophysiology and Therapeutic Potential of NADPH Oxidases in Ischemic Stroke‐Induced Oxidative Stress. Oxidative Medicine and Cellular Longevity. 2021(1). 6631805–6631805. 51 indexed citations
7.
Sun, Shanshan, Ruihong Zhao, Jianhua Hu, et al.. (2021). Proton Pump Inhibitor Therapy Does Not Affect Prognosis of Cirrhosis Patients With Acute Decompensation and Acute-on-Chronic Liver Failure: A Single-Center Prospective Study. Frontiers in Medicine. 8. 763370–763370. 5 indexed citations
8.
Xu, Chen, et al.. (2020). [Pregnant women complicated with COVID-19: a clinical analysis of 3 cases].. PubMed Central. 49(2). 240–244. 18 indexed citations
9.
Lu, Shaojia, Ning Wei, Jiajun Jiang, et al.. (2020). First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder. Journal of Affective Disorders. 277. 337–340. 54 indexed citations
10.
11.
Zhao, Hong, et al.. (2020). Transmission risk of patients with COVID-19 meeting discharge criteria should be interpreted with caution. Journal of Zhejiang University SCIENCE B. 21(5). 408–410. 5 indexed citations
12.
Ni, Qin, Cheng Ding, Yongtao Li, et al.. (2020). Effect of low-to-moderate dose glucocorticoids on viral clearance in COVID-19: a retrospective study. 13(1). 21–24. 4 indexed citations
13.
Fang, Hong, Sheng Tu, Jifang Sheng, & Anwen Shao. (2019). Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment. Journal of Cellular and Molecular Medicine. 23(4). 2324–2332. 701 indexed citations breakdown →
14.
Sheng, Jifang, et al.. (2019). Clinical characteristics and prognostic factors of 25 patients with new bunyavirus infection. 12(3). 152–157. 3 indexed citations
15.
Peng, Jie, Cheng‐Feng Qin, Xia Li, et al.. (2018). [Guidelines for diagnosis and treatment of dengue in China].. PubMed. 57(9). 642–648. 12 indexed citations
16.
Shi, Yu, Huadong Yan, Hong Fang, et al.. (2015). The Clinical Course of Cirrhosis Patients Hospitalized for Acute Hepatic Deterioration. Medicine. 94(47). e2031–e2031. 9 indexed citations
17.
Sheng, Jifang, et al.. (2014). Analysis and Forecast for Multidrug-Resistant Acinetobacter baumannii Infections Among Liver Transplant Recipients. Transplantation Proceedings. 46(5). 1448–1452. 2 indexed citations
18.
Xiang, Dairong, et al.. (2010). Expression level of augmenter of liver regeneration in patients with hepatic failure and hepatocellular carcinoma.. PubMed. 9(5). 492–8. 14 indexed citations
19.
Sun, Jing, Qing Xie, Jifang Sheng, et al.. (2009). 910 A PROSPECTIVE, RANDOMIZED STUDY OF EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2A VERSUS ADEFOVIR DIPIVOXIL IN TREATING LAMIVUDINE- RESISTANT HBeAg-POSITIVE CHB. Journal of Hepatology. 50. S330–S331. 6 indexed citations
20.
Xing, Huichun, Lanjuan Li, Kaijin Xu, et al.. (2004). Intestinal microflora in rats with ischemia/reperfusion liver injury. Journal of Zhejiang University SCIENCE B. 6(1). 14–21. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Guaraldi Breakdown of academic impact, for papers by Gabriel Chodick Breakdown of academic impact, for papers by Claudio Maria Mastroianni Breakdown of academic impact, for papers by Gianvincenzo Zuccotti Breakdown of academic impact, for papers by André Scherag Breakdown of academic impact, for papers by Melchor Álvarez‐Mon Breakdown of academic impact, for papers by Fang Liu Breakdown of academic impact, for papers by Ammarin Thakkinstian Breakdown of academic impact, for papers by Long H. Nguyen Breakdown of academic impact, for papers by Karla Soares‐Weiser
Rankless by CCL
2026